Evaluation and Management of Hearing Loss in Survivors of Childhood and Adolescent Cancers: A Report From the Children's Oncology Group.

Autor: Bass JK; Rehabiliation Services, St Jude Children's Research Hospital, Memphis, Tennessee., Knight KR; Child Development and Rehabilitation Center, Oregon Health and Science University, Portland, Oregon., Yock TI; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts., Chang KW; Department of Otolaryngology, Stanford University, Stanford, California., Cipkala D; Center for Cancer and Blood Diseases, Peyton Manning Children's Hospital at St. Vincent, Indianapolis, Indiana., Grewal SS; Pediatric Hematology-Oncology, Baystate Medical Center, Springfield, Massachusetts.
Jazyk: angličtina
Zdroj: Pediatric blood & cancer [Pediatr Blood Cancer] 2016 Jul; Vol. 63 (7), pp. 1152-62. Date of Electronic Publication: 2016 Feb 29.
DOI: 10.1002/pbc.25951
Abstrakt: Hearing loss (HL) is common in childhood cancer survivors exposed to platinum chemotherapy and/or cranial radiation and can severely impact quality of life. Early detection and appropriate management can mitigate academic, speech, language, social, and psychological morbidity resulting from hearing deficits. This review is targeted as a resource for providers involved in aftercare of childhood cancers. The goal is to promote early identification of survivors at-risk for HL, appropriate evaluation and interpretation of diagnostic tests, timely referral to an audiologist when indicated, and to increase knowledge of current therapeutic options.
(© 2016 Wiley Periodicals, Inc.)
Databáze: MEDLINE
Externí odkaz: